Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
Union Square Ventures
investor
United States
- New York, NY
- 07/12/2022
- Series A
- $9,300,000
USV is a small collegial partnership that manages over $1B across seven funds. Our portfolio companies create services that have the potential to fundamentally transform important markets.
- Industry Venture Capital and Private Equity Principals
- Website https://www.usv.com/
- LinkedIn https://www.linkedin.com/company/union-square-ventures/
Related People
Nick GrossmanInvestor
United States -
ND
Technologist & investor working to build the next generation of important internet platforms.
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)